3rd ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology

Description

Chairs: T. Cufer, SI - R. Herrmann, CH
ESO Masterclass Coordinator: N. Pavlidis, GR

This residential programme has been designed for young medical and clinical oncologists, who wish to improve their skills or those who are preparing for the national board or ESMO exam. The programme will expose participants to a full spectrum of issues in clinical and medical oncology from basic science to advanced knowledge of systemic therapy as well as in the multidisciplinary treatment approach. It is intended to cover all major topics of ESMO-ASCO curriculum on medical oncology.

The programme focuses on cancer pathology and molecular biology, cancer genetics, pharmacology of anti-cancer drugs and on frequent cancers such as breast, lung, gastro-intestinal, gynaecological and head and neck cancer. Spotlight sessions will provide inside on state of the art approaches in melanoma, sarcoma, thyroid cancer and on palliative care. Furthermore, practical training will be offered in the frame of clinical case presentations, prepared and presented by the participants and faculty for an interactive discussion.
All participants will reside at the Masterclass venue and participation is mandatory throughout the course. At the end of each of the five days a learning self-assessment discussion with the chairs of the course will be provided.

LEARNING OBJECTIVES
• Update the knowledge on basic science of clinical and medical oncology
• Enhance the competence and practical performance in systemic therapy of malignancies
• Enhance the competence and practical performance in multidisciplinary cancer care
• Update knowledge and get additional skills in supportive as well as palliative care
• Prepare for the board exam in clinical/medical oncology

MAIN TOPICS
• Cancer biology/pathology
• Cancer genetics
• Pharmacology of anti-cancer drugs
• Breast cancer
• Gastro-intestinal tumours
• Lung cancer and mesothelioma
• Genito-urinary cancers
• Palliative and supportive care
• Haematological malignancies

THE MASTERCLASS IS:
• A five day residential, educational event
• Full immersion
• Clinically oriented
• Multidisciplinary



The Eastern Europe and Balkan Region Masterclass in Medical Oncology is an ESO-ESMO joint event

General information

ORGANISING SECRETARIAT
Alexandra Zampetti and Dolores Knupfer
European School of Oncology (ESO)
Piazza Indipendenza, 2
6500 Bellinzona, Switzerland
Email: azampetti@eso.net or dknupfer@eso.net
Tel: +41 91 820 09 52/54

CME ACCREDITATION AND CERTIFICATE
The 3rd ESO-ESMO Eastern Europe and Balkan Region Masterclass in Medical Oncology is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net

The programme has been granted up to 28 European CME credits (ECMEC). Each medical specialist should claim only those hours of credit that he/she actually spent in the educational activity.

Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™. Information on the process to convert EACCME credit to AMA credit can be found at www.ama-assn.org/go/internationalcme

Live educational activities, occurring outside of Canada, recognized by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

The programme is furthermore accredited with 25 ESMO-MORA category 1 points.

Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.

Faculty list

FACULTY (as of March 2016)
P. Berzinec, Institute of Tuberculosis and Respiratory Diseases, Nitra-Zobor, SK
J. Beyer, University Hospital Zürich, CH
M.J. Cardoso, Champalimaud Cancer Center, Lisbon, PT
A. Cervantes, University of Valencia, Valencia, ES
A. Costa, CEO, European School of Oncology, Milan, IT and Bellinzona, CH
T. Cufer, University Clinic Golnik, SI
M. Ebert Moltara, Oncology Institute, Ljubljana, SI
A. Eniu, Cancer Institute « I. Chiricuta”, Cluj-Napoca, RO
M.F. Fey, Inselspital, Berne, CH
A. Fusi, Charité Comprehensive Cancer Center, Berlin, DE
K. Heinimann, University Hospital, Basel, CH
R. Herrmann, University Hospital, Basel, CH
M.A. Hoda, Medical University Vienna, AT
M. Joerger, Cantonal Hospital St. Gallen, CH
D. Jovanovic, Clinical Center of Serbia, Belgrade, RS
I. Kern, University Clinic Golnik, SI
F. Krasniqi, University Hospital Basel, CH
T. Marinko, Institute of Oncology Ljubljana, SI
N. Pavlidis, University Hospital of Ioannina, GR
R. Popescu, Hirslanden Klinik Aarau, CH
A. Reiner, Donau Hospital SMZO, Vienna, AT
P. Roth, University Hospital Zürich, CH
S. Rothschild, University Hospital Basel, CH
B. Šeruga, Institute of Oncology, Ljubljana, SI
C. Sessa, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
S. Spanik, St. Elizabeth Cancer Institute, Bratislava, SK
P. Strojan, Institute of Oncology, Ljubljana, SI

Programme

20 May


		Participants arrivals
20:00		Dinner

21 May


8:15		Registration
9:00		Welcome address and general introduction T. Cufer, SI - R. Herrmann, CH
CANCER BIOLOGY Chair: A. Reiner, AT
9:30		Biology of cancer S. Rothschild, CH
10:00		Discussion
10:10		Cancer genetics for the practising oncologist K. Heinimann, CH
10:40		Discussion
10:50		Coffee break
*SPOTLIGHT SESSION 1* Chair: S. Rothschild, CH
11:10		Pharmacology of anticancer drugs and drug interactions M. Joerger, CH
11:55		Discussion
12:05		Basic principles of immunotherapy and melanoma A. Fusi, DE
12:50		Discussion
13:00		Lunch
*SPOTLIGHT SESSION 2* Chair: R. Herrmann, CH
14:30		Palliative care M. Ebert Moltara, SI
14:50		Discussion
15:00		Supportive care M. Ebert Moltara, SI
15:20		Discussion
15:30		Coffee break
16:00		Head and neck cancers P. Strojan, SI
16:20		Discussion
16:30		Sarcomas including GIST F. Krasniqi, CH
16:50		Discussion
17:00		CNS malignancies P. Roth, CH
17:20		Discussion
17:30 -18:30		Participants' case presentations - Group 1 (4 cases) - T. Cufer, SI - A. Eniu, RO - Group 2 (4 cases) - R. Herrmann, CH - Group 3 (4 cases) - N. Pavlidis, GR
20:00		Dinner

22 May


GASTRO-INTESTINAL TUMOURS Chairs: R. Popescu, CH - A. Cervantes, ES

9:00		Management of esophageal cancer and gastric cancer A. Cervantes, ES
9:45		Discussion
10:00		Management of early and locally advanced colorectal cancer S. Spanik, SK
10:45		Discussion
10:55		Coffee break
11:05		Tumor board: Gastro-intestinal tumors: PART 1 Panellists: A. Cervantes, ES - R. Popescu, CH - S. Spanik, SK (4 cases)
11:55		Systemic treatment of advanced colorectal cancer R. Popescu, CH
12:40		Discussion
12:50		Lunch
14:15		New developments in systemic treatment of hepatobiliary and pancreatic cancer R. Popescu, CH
14:35		Discussion
14:45		Tumor board: Gastro-intestinal tumors: PART 2 Panellists: A. Cervantes, ES - R. Popescu, CH - S. Spanik, SK (4 cases)
15:45		Coffee break
16:00		Spotlight session 3 Chair: T. Cufer, SI
16:15		Cancer of unknown primary N. Pavlidis, GR
16:35		Discussion
16:45		Neuroendocrine tumors N. Pavlidis, GR
17:05		Discussion
17:15 -18:15		Participants' case presentations - Group 1 (4 cases) - T. Cufer, SI - A. Eniu, RO - Group 2 (4 cases) - R. Herrmann, CH - Group 3 (4 cases) - N. Pavlidis, GR
20:00		Dinner

23 May


BREAST CANCER Chairs: A. Eniu, RO - B. Šeruga, SI
9:00		Breast cancer pathology and molecular biology A. Reiner, AT
9:30		Discussion
9:40		Optimal surgical management of breast cancer M.J. Cardoso, PT
10:00		Discussion
10:10		The role of radiotherapy in early and advanced BC T. Marinko, SI
10:30		Discussion
10:40		Coffee break
11:00		Optimal approach in locally advanced disease: ESO-ESMO ABC Guidelines A. Eniu, RO
11:30		Discussion
11:40		Tumor board: Breast cancer: PART 1 Panellists: M.J. Cardoso, PT - T. Cufer, SI - A. Eniu, RO - T. Marinko, SI - A. Reiner, AT - B. Šeruga, SI (4 cases)
12:40		Lunch
14:00		Systemic treatment of Luminal early and advanced BC B. Šeruga, SI
14:30		Discussion
14:40		Systemic treatment of HER2-positive early and advanced BC T. Cufer, SI
15:10		Discussion
15:20		Systemic treatment of TN early and advanced BC A. Eniu, RO
15:50		Discussion
16:00		Coffee break
16:15		Tumor board: Breast cancer: PART 2 Panellists: M.J. Cardoso, PT - T. Cufer, SI - A. Eniu, RO - T. Marinko, SI - A. Reiner, AT - B. Šeruga, SI (4 cases)
SPOTLIGHT SESSION 4 Chair: R. Popescu, CH
17:15		Targeted therapies of renal cell carcinoma S. Rothschild, CH
17:35		Discussion
17:35 -18:45		Learning self-assessment discussion R. Herrmann, CH
20:00		Off-site dinner: Bratislava Castle

24 May


LUNG CANCER AND MESOTHELIOMA Chairs: T. Cufer, SI - D. Jovanovic, RS
9:00		Lung cancer pathology and molecular biology I. Kern, SI
9:30		Discussion
9:40		Surgery of lung cancer and mesothelioma M.A. Hoda, AT
10:10		Discussion
10:20		Optimal management of N2 disease D. Jovanovic, RS
10:50		Discussion
11:00		Coffee break
11:15		Tumor board: Lung cancer - PART 1 Panellists: T. Cufer, SI – I. Kern, SI - D. Jovanovic, RS - P. Berzinec, SK - M.A. Hoda, AT (4 cases)
12:15		Systemic therapy of NSCLC T. Cufer, SI
12:45		Discussion
12:55		Lunch
14:15		Treatment of SCLC P. Berzinec, SK
14:35		Discussion
14:45		Mesothelioma D. Jovanovic, RS
15:05		Discussion
15:15		Tumor board: Lung cancer PART 2 Panellists: T. Cufer, SI – I. Kern, SI - D. Jovanovic, RS - P. Berzinec, SK - M.A. Hoda, AT (4 cases)
16:15		Coffee break
SPOTLIGHT SESSION 5 Chair: D. Jovanovic, RS
16:30		New developments in systemic treatment of gynecological cancers C. Sessa, CH
17:05		Discussion
17:15		Assessment of patients’ comorbidity and comprehensive geriatric assessment B. Šeruga, SI
17:50		Discussion
20:00		Dinner

25 May


GENITO-URINARY CANCERS Chair: R. Herrmann, CH
8:30		New developments in systemic therapy of germ cell tumors J. Beyer, CH
9:00		Discussion
9:10		Systemic therapy of bladder cancer B. Šeruga, SI
9:40		Discussion
9:50		Systemic therapy of prostate cancer J. Beyer, CH
10:35		Discussion
11:25		Tumor board: Genito-urinary Panellists: J. Beyer, CH - B. Šeruga, SI (4 cases)
12:25		Brunch
SPOTLIGHT SESSION 6 Chair: T. Cufer, SI
13:00		Introduction A. Costa, CH/IT
13:05		Hiba Basic Memorial Lecture: Personalised Medicine in 2016: realities and future hopes M.F. Fey, CH
13:50		Discussion
14:00		Close T. Cufer, SI
		Departures